CJS Securities analyst Jonathan Tanwanteng upgrades Vicor (NASDAQ:VICR) from Market Perform to Market Outperform.
Credit Suisse Initiates Coverage On Eli Lilly with Outperform Rating, Announces Price Target of $395
Credit Suisse analyst Trung Huynh initiates coverage on Eli Lilly (NYSE:LLY) with a Outperform rating and announces Price Target of $395.